Tag: Tabrecta
Novartis: European green light for Tabrecta against lung cancer
Zurich (awp) – Novartis has obtained marketing authorization from the European Commission for its Tabrecta (capmatinib), in the indication against an advanced form of non-small cell lung cancer. The multinational…